Endothelial and Antithrombotic Actions of HDL
Top Cited Papers
- 9 June 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (11) , 1352-1364
Abstract
It is well recognized that high-density lipoprotein (HDL)-cholesterol is antiatherogenic and serves a role in mediating cholesterol efflux from cells. However, HDL has multiple additional endothelial and antithrombotic actions that may also afford cardiovascular protection. HDL promotes the production of the atheroprotective signaling molecule nitric oxide (NO) by upregulating endothelial NO synthase (eNOS) expression, by maintaining the lipid environment in caveolae where eNOS is colocalized with partner signaling molecules, and by stimulating eNOS as a result of kinase cascade activation by the high-affinity HDL receptor scavenger receptor class B type I (SR-BI). HDL also protects endothelial cells from apoptosis and promotes their growth and their migration via SR-BI–initiated signaling. As importantly, there is evidence of a variety of mechanisms by which HDL is antithrombotic and thereby protective against arterial and venous thrombosis, including through the activation of prostacyclin synthesis. The antithrombotic properties may also be related to the abilities of HDL to attenuate the expression of tissue factor and selectins, to downregulate thrombin generation via the protein C pathway, and to directly and indirectly blunt platelet activation. Thus, in addition to its cholesterol-transporting properties, HDL favorably regulates endothelial cell phenotype and reduces the risk of thrombosis. With further investigation and resulting greater depth of understanding, these mechanisms may be harnessed to provide new prophylactic and therapeutic strategies to combat atherosclerosis and thrombotic disorders.Keywords
This publication has 130 references indexed in Scilit:
- Receptors, rafts, and microvesicles in thrombosis and inflammationJournal of Thrombosis and Haemostasis, 2005
- A Novel Ligand-independent Apoptotic Pathway Induced by Scavenger Receptor Class B, Type I and Suppressed by Endothelial Nitric-oxide Synthase and High Density LipoproteinJournal of Biological Chemistry, 2005
- Oxidised‐HDL3 induces the expression of PAI‐1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilizationBritish Journal of Haematology, 2004
- Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox‐2 expression by VSMCEuropean Journal of Clinical Investigation, 2003
- High Density Lipoprotein-induced Signaling of the MAPK Pathway Involves Scavenger Receptor Type BI-mediated Activation of RasJournal of Biological Chemistry, 2003
- Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated LysosphingolipidsJournal of Biological Chemistry, 2001
- High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced ApoptosisBiochemical and Biophysical Research Communications, 2000
- Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal CaveolaeJournal of Biological Chemistry, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989